tradingkey.logo
tradingkey.logo
Search

Heron Therapeutics Inc

HRTX
Add to Watchlist
0.371USD
+0.078+26.62%
Close 11-06 16:00(ET)
70.43MMarket Cap
LossP/E TTM
After-hours 19:29 (ET)0.395USD+0.028+7.63%

Today

+26.62%

5 Days

+25.76%

1 Month

+3.63%

6 Months

-69.34%

Year to Date

-71.46%

1 Year

-66.27%

Key Figures

0.368Open
0.420High
3.08MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.62%Turnover Ratio
0.293Prev. Close
0.277Low
1.18MTurnover
LossP/E Static
11.89P/B
0.00%Div Yield TTM
-12.84%ROA
1.58052wk High
2.70Volume Ratio
-13.58MNet Profit
189.85MShares
-0.1811EPS TTM
1.62Beta
-2408.88%ROE
0.26152wk Low
48.80%Amplitude
69.28%Gross Margin
70.43MMarket Cap
-6.57Reward/Risk
5.83%Risk Rate
More news coming soon, stay tuned...

Heron Therapeutics Inc's Score

0.04vs previous score
Forecast6.00
Financial Health7.92
Technical5.59
Valuation Dimensions8.14
Institutional Confidence10.00
Risk Assessment1.97

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
HoldCurrent Rating
2.500Target Price
+409.37%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy00000000
Buy00113333
Hold22110000
Sell00000000
Strong Sell00000000

Heron Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.03/0.01
Revenue / Forecast
37.67M/42.20M

Heron Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolHRTX
Number of employees122
CountryUnited States of America

Ownership

ShareholdersProportion
Rubric Capital Management LP15.87%
Clearline Capital LP6.46%
Adage Capital Management, L.P.5.91%
BlackRock Institutional Trust Company, N.A.4.92%
Shareholder TypesProportion
Hedge Fund42.26%
Investment Advisor22.94%
Investment Advisor/Hedge Fund15.47%
Research Firm1.62%

FAQs

What is the current price of Heron Therapeutics Inc (HRTX)?

The current price of Heron Therapeutics Inc (HRTX) is 0.37.

What is the symbol of Heron Therapeutics Inc?

The ticker symbol of Heron Therapeutics Inc is HRTX.

What is the 52-week high of Heron Therapeutics Inc?

The 52-week high of Heron Therapeutics Inc is 1.58.

What is the 52-week low of Heron Therapeutics Inc?

The 52-week low of Heron Therapeutics Inc is 0.26.

What is the market capitalization of Heron Therapeutics Inc?

The market capitalization of Heron Therapeutics Inc is 70.43M.

Is Heron Therapeutics Inc (HRTX) currently rated as Buy, Hold, or Sell?

According to analysts, Heron Therapeutics Inc (HRTX) has an overall rating of signal_hold, with a price target of 2.50.

What is the Earnings Per Share (EPS TTM) of Heron Therapeutics Inc (HRTX)?

The Earnings Per Share (EPS TTM) of Heron Therapeutics Inc (HRTX) is -0.18.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.